Patent: 10,363,324
✉ Email this page to a colleague
Summary for Patent: 10,363,324
| Title: | Pharmaceutical composition |
| Abstract: | This invention relates to a pharmaceutical composition for parenteral or oral administration containing a radioactive compound which can be used diagnostically or therapeutically. The composition comprises a micro-emulsion constituted by a dispersion of vesicles or microsponges of a fatty acid based component in an aqueous or other pharmacologically acceptable carrier in which nitrous oxide is dissolved, the fatty acid based component comprising at least one long chain fatty acid based substance selected from the group consisting of free fatty acids and derivatives of free fatty acids, and the radioactive compound. |
| Inventor(s): | Grobler; Anne Frederica (North West Province, ZA), Zeevaart; Jan Rijn (Pelindaba, ZA) |
| Assignee: | The South African Nuclear Energy Corporation Limited (Brits Magisterial District, ZA) North-West University (Potchefstroom, ZA) |
| Application Number: | 15/034,281 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,363,324
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharma Gmbh & Co. Kg | VERLUMA | nofetumomab | Injection | 103769 | October 13, 1998 | ⤷ Start Trial | 2034-11-04 |
| Acrotech Biopharma Inc. | ZEVALIN | ibritumomab tiuxetan | Injection | 125019 | February 19, 2002 | ⤷ Start Trial | 2034-11-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
